Neuronetics Inc
STIM1.560USD
+0.140+9.86%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
106.77M시가총액
손실P/E TTM
자세한 내용은 Neuronetics Inc 회사
Neuronetics, Inc. a vertically integrated, commercial stage, medical technology and healthcare company. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The Company provides more than 7.1 million treatments to over 1,95,000 patients.
Neuronetics Inc 정보
종목 코드 STIM
회사 이름Neuronetics Inc
상장일Jun 28, 2018
CEOMr. Keith J. Sullivan
직원 수716
유형Ordinary Share
회계 연도 종료Jun 28
주소3222 Phoenixville Pike
도시MALVERN
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호19355
전화18776007555
웹사이트https://neurostar.com/neuronetics/
종목 코드 STIM
상장일Jun 28, 2018
CEOMr. Keith J. Sullivan
Neuronetics Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Sasha Cucuz
Mr. Sasha Cucuz
Director
Director
2.03M
+6410.00%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
588.77K
+10531.00%
Mr. Steven Pfanstiel
Mr. Steven Pfanstiel
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
570.21K
+170212.00%
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
335.45K
+7554.00%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
185.35K
+7326.00%
Ms. Megan Rosengarten
Ms. Megan Rosengarten
Independent Director
Independent Director
140.89K
+30000.00%
Mr. Mark Klausner
Mr. Mark Klausner
Managing Partner
Managing Partner
--
--
Mr. W. Andrew Macan
Mr. W. Andrew Macan
Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
--
--
Dr. Avinash N. Amin, M.D.
Dr. Avinash N. Amin, M.D.
Director
Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Sasha Cucuz
Mr. Sasha Cucuz
Director
Director
2.03M
+6410.00%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
588.77K
+10531.00%
Mr. Steven Pfanstiel
Mr. Steven Pfanstiel
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
570.21K
+170212.00%
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
335.45K
+7554.00%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
185.35K
+7326.00%
Ms. Megan Rosengarten
Ms. Megan Rosengarten
Independent Director
Independent Director
140.89K
+30000.00%
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Clinic revenue
21.81M
58.47%
Treatment sessions
10.76M
28.84%
NeuroStar Advanced Therapy System
3.96M
10.61%
Other
776.00K
2.08%
지역별USD
이름
수익
비율
United States
36.25M
97.19%
International
1.05M
2.81%
사업별
지역별
사업별USD
이름
수익
비율
Clinic revenue
21.81M
58.47%
Treatment sessions
10.76M
28.84%
NeuroStar Advanced Therapy System
3.96M
10.61%
Other
776.00K
2.08%
주식 보유 통계
마지막 업데이트: Fri, Jan 2
마지막 업데이트: Fri, Jan 2
주주
주주 유형
주주
주주
비율
Madryn Asset Management, LP
30.28%
Chernett (Jorey)
9.97%
UBS Financial Services, Inc.
3.81%
The Vanguard Group, Inc.
3.77%
BlackRock Institutional Trust Company, N.A.
3.10%
기타
49.08%
주주
주주
비율
Madryn Asset Management, LP
30.28%
Chernett (Jorey)
9.97%
UBS Financial Services, Inc.
3.81%
The Vanguard Group, Inc.
3.77%
BlackRock Institutional Trust Company, N.A.
3.10%
기타
49.08%
주주 유형
주주
비율
Private Equity
30.28%
Individual Investor
19.61%
Investment Advisor
13.93%
Hedge Fund
9.59%
Investment Advisor/Hedge Fund
6.14%
Research Firm
1.71%
Bank and Trust
0.10%
Pension Fund
0.05%
Venture Capital
0.04%
기타
18.55%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
216
42.40M
61.91%
-15.44M
2025Q3
198
39.45M
57.60%
-13.65M
2025Q2
187
47.56M
71.93%
-4.03M
2025Q1
191
47.19M
71.70%
-4.84M
2024Q4
155
36.70M
70.38%
+11.74M
2024Q3
153
14.58M
47.42%
-9.85M
2024Q2
159
20.22M
66.61%
-5.87M
2024Q1
183
20.38M
68.24%
-3.49M
2023Q4
191
18.37M
63.28%
-7.87M
2023Q3
201
19.69M
68.24%
-8.69M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Madryn Asset Management, LP
20.74M
30.28%
-3.50M
-14.44%
Aug 08, 2025
Chernett (Jorey)
4.40M
6.43%
+4.40M
--
Nov 17, 2025
UBS Financial Services, Inc.
2.16M
3.16%
+1.85M
+580.70%
Sep 30, 2025
The Vanguard Group, Inc.
2.83M
4.14%
+89.50K
+3.26%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.12M
3.1%
+75.30K
+3.68%
Sep 30, 2025
Cucuz (Sasha)
2.03M
2.97%
+6.41K
+0.32%
Oct 20, 2025
Balyasny Asset Management LP
1.82M
2.66%
+312.55K
+20.71%
Sep 30, 2025
Sullivan (Keith J)
1.61M
2.35%
--
--
Mar 24, 2025
Wexford Capital LP
1.18M
1.72%
+534.15K
+83.06%
Sep 30, 2025
Masters Capital Management, L.L.C.
1.00M
1.46%
--
--
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
AdvisorShares Psychedelics ETF
3.31%
Invesco NASDAQ Future Gen 200 ETF
0.43%
iShares Neuroscience and Healthcare ETF
0.1%
Vanguard US Momentum Factor ETF
0.04%
iShares Micro-Cap ETF
0.02%
iShares Russell 2000 Growth ETF
0.01%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.01%
Avantis US Small Cap Equity ETF
0%
ProShares Hedge Replication ETF
0%
Proshares Ultra Russell 2000
0%
더 보기
AdvisorShares Psychedelics ETF
비율3.31%
Invesco NASDAQ Future Gen 200 ETF
비율0.43%
iShares Neuroscience and Healthcare ETF
비율0.1%
Vanguard US Momentum Factor ETF
비율0.04%
iShares Micro-Cap ETF
비율0.02%
iShares Russell 2000 Growth ETF
비율0.01%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
비율0.01%
Avantis US Small Cap Equity ETF
비율0%
ProShares Hedge Replication ETF
비율0%
Proshares Ultra Russell 2000
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
